Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China
· Delayed Price · Currency is CNY 15.26
-0.10 (-0.65%)
Apr 2, 2025, 2:45 PM CST
SHA:603858 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 16,263 | 18,814 | 23,238 | 23,326 | 25,516 | 22,807 | Upgrade
|
| Market Cap Growth | -2.46% | -19.04% | -0.38% | -8.58% | 11.88% | 1.79% | Upgrade
|
| Enterprise Value | 18,525 | 21,044 | 23,744 | 25,505 | 27,096 | 23,121 | Upgrade
|
| Last Close Price | 15.26 | 16.87 | 19.83 | 19.52 | 20.79 | 17.63 | Upgrade
|
| PE Ratio | - | 58.98 | - | 18.09 | 13.71 | 11.72 | Upgrade
|
| Forward PE | - | 25.13 | 25.13 | 25.13 | 25.13 | 25.13 | Upgrade
|
| PS Ratio | 1.42 | 1.42 | 1.55 | 1.48 | 1.59 | 1.60 | Upgrade
|
| PB Ratio | 1.46 | 1.65 | 1.89 | 1.61 | 1.85 | 1.65 | Upgrade
|
| P/TBV Ratio | 2.19 | 2.05 | 2.52 | 2.87 | 3.47 | 3.16 | Upgrade
|
| P/FCF Ratio | 27.81 | - | 10.50 | 26.30 | 17.94 | 11.64 | Upgrade
|
| P/OCF Ratio | 21.07 | - | 8.43 | 17.67 | 13.03 | 8.70 | Upgrade
|
| EV/Sales Ratio | 1.57 | 1.59 | 1.59 | 1.62 | 1.69 | 1.62 | Upgrade
|
| EV/EBITDA Ratio | 19.58 | 14.55 | 10.53 | 11.42 | 9.99 | 8.69 | Upgrade
|
| EV/EBIT Ratio | 32.39 | 20.32 | 13.37 | 14.65 | 11.85 | 10.16 | Upgrade
|
| EV/FCF Ratio | 31.68 | - | 10.73 | 28.76 | 19.05 | 11.80 | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.29 | 0.27 | 0.25 | 0.25 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 4.15 | 2.25 | 1.45 | 1.57 | 1.27 | 1.02 | Upgrade
|
| Debt / FCF Ratio | 6.72 | - | 1.49 | 3.99 | 2.43 | 1.39 | Upgrade
|
| Asset Turnover | 0.58 | 0.62 | 0.65 | 0.67 | 0.73 | 0.69 | Upgrade
|
| Inventory Turnover | 1.06 | 0.99 | 1.12 | 1.25 | 1.59 | 1.44 | Upgrade
|
| Quick Ratio | 0.46 | 0.45 | 0.71 | 0.57 | 0.62 | 0.78 | Upgrade
|
| Current Ratio | 1.24 | 1.21 | 1.29 | 1.17 | 1.02 | 1.15 | Upgrade
|
| Return on Equity (ROE) | -4.04% | 1.28% | -11.91% | 8.74% | 13.36% | 14.20% | Upgrade
|
| Return on Assets (ROA) | 1.75% | 3.02% | 4.83% | 4.64% | 6.49% | 6.90% | Upgrade
|
| Return on Capital (ROIC) | 2.37% | 4.28% | 6.61% | 6.17% | 8.46% | 8.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.10% | 7.40% | 11.80% | 10.30% | 15.20% | 15.10% | Upgrade
|
| Earnings Yield | -1.80% | 1.70% | -6.58% | 5.53% | 7.29% | 8.53% | Upgrade
|
| FCF Yield | 3.60% | -3.86% | 9.52% | 3.80% | 5.57% | 8.59% | Upgrade
|
| Dividend Yield | 0.82% | 0.75% | 4.84% | 1.84% | 2.53% | 9.15% | Upgrade
|
| Payout Ratio | 0.00% | 374.41% | - | 57.88% | 133.71% | 47.31% | Upgrade
|
| Buyback Yield / Dilution | 1.09% | 0.00% | 0.01% | -0.01% | 0.87% | 2.26% | Upgrade
|
| Total Shareholder Return | 1.91% | 0.75% | 4.85% | 1.84% | 3.40% | 11.41% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.